Moderna requests authorization for COVID-19 vaccine for children under 6

Published



Moderna announced it would request authorization from the Food and Drug Administration to administer a smaller dose of its COVID-19 vaccine to children ages 6 months old to 6 years old.

Clinical trial data showed that children under 6 mounted a robust neutralizing antibody response comparable to young adults when given a dose a quarter as strong, the company said on Wednesday.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.